Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors

NCT02441062 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors
Carcinoid Tumors
Neuroblastoma
Medulloblastoma

Interventions

DRUG: 68Ga-DOTATOC PET/CT

Sponsor

Sue O'Dorisio

Collaborators

[object Object]